These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19364065)
1. Exon skipping, a therapy for Duchenne muscular dystrophy. Interview by Guenter Scheuerbrandt. Platenburg G Acta Myol; 2008 Oct; 27():69-73. PubMed ID: 19364065 [No Abstract] [Full Text] [Related]
2. Antisense oligonucleotide drugs for Duchenne muscular dystrophy: how far have we come and what does the future hold? Guncay A; Yokota T Future Med Chem; 2015; 7(13):1631-5. PubMed ID: 26423833 [No Abstract] [Full Text] [Related]
3. Less is more: therapeutic exon skipping for Duchenne muscular dystrophy. Aartsma-Rus A; van Ommen GJ Lancet Neurol; 2009 Oct; 8(10):873-5. PubMed ID: 19713153 [No Abstract] [Full Text] [Related]
4. Overview on DMD exon skipping. Aartsma-Rus A Methods Mol Biol; 2012; 867():97-116. PubMed ID: 22454057 [TBL] [Abstract][Full Text] [Related]
9. Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge. Wood MJ Sci Transl Med; 2010 Mar; 2(25):25ps15. PubMed ID: 20424011 [TBL] [Abstract][Full Text] [Related]
10. [Advances of treatment for Duchenne muscular dystrophy with exon skipping]. Yang J; Zhang C Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Aug; 28(4):406-8. PubMed ID: 21811980 [TBL] [Abstract][Full Text] [Related]